Cargando…

Epigenetic modifications as therapeutic targets in atherosclerosis: a focus on DNA methylation and non-coding RNAs

Significant progress in the diagnosis and treatment of cardiovascular disease (CVD) has been made in the past decade, yet it remains a leading cause of morbidity and mortality globally, claiming an estimated 17.9 million deaths per year. Although encompassing any condition that affects the circulato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sum, Hashum, Brewer, Alison C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248074/ https://www.ncbi.nlm.nih.gov/pubmed/37304954 http://dx.doi.org/10.3389/fcvm.2023.1183181

Ejemplares similares

Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs
por: Fadaei, Sara, et al.
Publicado: (2022)

Non-coding RNA-Associated Therapeutic Strategies in Atherosclerosis
por: Tang, Yuyan, et al.
Publicado: (2022)

Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications
por: Elia, Leonardo, et al.
Publicado: (2017)

Diverse Epigenetic Regulations of Macrophages in Atherosclerosis
por: Yang, Hongmei, et al.
Publicado: (2022)

Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis
por: Gualtierotti, Roberta, et al.
Publicado: (2023)

Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability
por: Shen, Xinyi, et al.
Publicado: (2021)

Mechanisms of Action of MiRNAs and LncRNAs in Extracellular Vesicle in Atherosclerosis
por: Xu, Hui, et al.
Publicado: (2021)

Algal Polysaccharides as Therapeutic Agents for Atherosclerosis
por: Patil, Nikita P., et al.
Publicado: (2018)

The Long Non-coding RNA AC148477.2 Is a Novel Therapeutic Target Associated With Vascular Smooth Muscle Cells Proliferation of Femoral Atherosclerosis
por: Wang, Kangjie, et al.
Publicado: (2022)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
por: Kumari, Himani, et al.
Publicado: (2020)

Non-coding RNAs to regulate cardiomyocyte proliferation: A new trend in therapeutic cardiac regeneration
por: Qin, Kele, et al.
Publicado: (2022)

Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms
por: Malekmohammad, Khojasteh, et al.
Publicado: (2021)

Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
por: Jing, Lele, et al.
Publicado: (2022)

Multi-Omics Approaches to Study Long Non-coding RNA Function in Atherosclerosis
por: Turner, Adam W., et al.
Publicado: (2019)

The Combined Regulation of Long Non-coding RNA and RNA-Binding Proteins in Atherosclerosis
por: Ding, Yuanyuan, et al.
Publicado: (2021)

Long Non-Coding RNAs in Vascular Inflammation
por: Haemmig, Stefan, et al.
Publicado: (2018)

Into the Wild: GWAS Exploration of Non-coding RNAs
por: Giral, Hector, et al.
Publicado: (2018)

Editorial: Non-coding RNAs in heart failure
por: Booz, George W., et al.
Publicado: (2022)

Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis
por: Li, Feifei, et al.
Publicado: (2017)

The Emerging Role of Long Non-coding RNAs and Circular RNAs in Coronary Artery Disease
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021)

Deciphering Non-coding RNAs in Cardiovascular Health and Disease
por: Das, Anindita, et al.
Publicado: (2018)

Non-coding RNAs Regulate the Pathogenesis of Aortic Dissection
por: Hu, Yu-Yuan, et al.
Publicado: (2022)

Non-coding RNAs: Important participants in cardiac fibrosis
por: Dong, Yiheng, et al.
Publicado: (2022)

Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation
por: Li, Dan, et al.
Publicado: (2022)

Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: A potential therapeutic target
por: Xu, Han, et al.
Publicado: (2022)

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity
por: Robinson, Emma L., et al.
Publicado: (2023)

Editorial: The role of genetics and non-coding RNAs in atrial fibrillation
por: Novelli, Valeria, et al.
Publicado: (2022)

Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases
por: Cai, Yuxi, et al.
Publicado: (2022)

Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome
por: Biolo, Gianni, et al.
Publicado: (2022)

Recent Insight on the Non-coding RNAs in Mesenchymal Stem Cell-Derived Exosomes: Regulatory and Therapeutic Role in Regenerative Medicine and Tissue Engineering
por: Pant, Tarun, et al.
Publicado: (2021)

Yes-Associated Protein in Atherosclerosis and Related Complications: A Potential Therapeutic Target That Requires Further Exploration
por: Sun, Congrui, et al.
Publicado: (2021)

The role of miRNAs in the diagnosis of stable atherosclerosis of different arterial territories: A critical review
por: Teixeira, Ana Rita, et al.
Publicado: (2022)

Foam Cells as Therapeutic Targets in Atherosclerosis with a Focus on the Regulatory Roles of Non-Coding RNAs
por: Javadifar, Amin, et al.
Publicado: (2021)

Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs
por: Lian, Yishui, et al.
Publicado: (2018)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

The Role of Long Non-coding RNAs in Sepsis-Induced Cardiac Dysfunction
por: Li, Jiawen, et al.
Publicado: (2021)

Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling
por: Parichatikanond, Warisara, et al.
Publicado: (2020)

Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
por: Li, Junyi, et al.
Publicado: (2021)

MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
por: Chen, Liuying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_apri1lnv9vlm3ct8u27m6mnbjc